These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27113954)

  • 21. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
    Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amisulpride treatment for clozapine-induced sialorrhea.
    Praharaj SK; Sarkar S; Sinha VK
    J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
    [No Abstract]   [Full Text] [Related]  

  • 23. Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea.
    Sharma A; Ramaswamy S; Dahl E; Dewan V
    Ann Pharmacother; 2004 Sep; 38(9):1538. PubMed ID: 15252196
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clozapine-induced hypersalivation and its treatment].
    Soler Roibal MA; Oca Bravo L; Montejo Iglesias LM
    Actas Esp Psiquiatr; 1999; 27(6):408-11. PubMed ID: 10611565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycopyrrolate for clozapine-induced sialorrhea.
    Duggal HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1546-7. PubMed ID: 17614181
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea.
    Rajagopal V; Sundaresan L; Rajkumar AP; Chittybabu C; Kuruvilla A; Srivastava A; Balasubramanian P; Jacob KS; Jacob M
    Psychiatr Genet; 2014 Dec; 24(6):273-6. PubMed ID: 25304228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scolpolamine patch for clozapine-induced sialorrhea.
    Gaftanyuk O; Trestman RL
    Psychiatr Serv; 2004 Mar; 55(3):318. PubMed ID: 15001737
    [No Abstract]   [Full Text] [Related]  

  • 28. Sublingual atropine in the treatment of clozapine-induced sialorrhea.
    Matos Santana TE; Capurso NA; Ranganathan M; Yoon G
    Schizophr Res; 2017 Apr; 182():144-145. PubMed ID: 27816262
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
    Mubaslat O; Lambert T
    Psychopharmacology (Berl); 2020 Oct; 237(10):2905-2915. PubMed ID: 32876732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
    Calderon J; Rubin E; Sobota WL
    Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biperiden for excessive sweating from clozapine.
    Richardson C; Kelly DL; Conley RR
    Am J Psychiatry; 2001 Aug; 158(8):1329-30. PubMed ID: 11481174
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
    Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
    Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options in the treatment of clozapine-induced sialorrhea.
    Rogers DP; Shramko JK
    Pharmacotherapy; 2000 Sep; 20(9):1092-5. PubMed ID: 10999502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study.
    Takeuchi I; Hanya M; Uno J; Fujita K; Kamei H
    Asia Pac Psychiatry; 2017 Dec; 9(4):. PubMed ID: 29193710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of clozapine-induced sialorrhea and its effect on quality of life.
    Sanagustin D; Martin-Subero M; Hogg B; Fortea L; Gardoki I; Guinart D; Roldán M; Angelats M; Cerro L; Navas D; Jiménez JD; Ortiz L; Ros R; Polo X; Ventura Y; Contreras J; Moreno-Alcázar A; Pérez-Sola V; Amann BL; Valiente-Gómez A
    Psychopharmacology (Berl); 2023 Jan; 240(1):203-211. PubMed ID: 36538098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moclobemide treatment of clozapine-induced hypersalivation: pilot open study.
    Kreinin A; Miodownik C; Libov I; Shestakova D; Lerner V
    Clin Neuropharmacol; 2009; 32(3):151-3. PubMed ID: 19483481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect.
    Antonello C; Tessier P
    J Psychiatry Neurosci; 1999 May; 24(3):250. PubMed ID: 10354662
    [No Abstract]   [Full Text] [Related]  

  • 39. Salivary flow rate in patients with schizophrenia on clozapine.
    Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK
    Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspiration Pneumonia Due to Clozapine-Induced Sialorrhea.
    Saenger RC; Finch TH; Francois D
    Clin Schizophr Relat Psychoses; 2016; 9(4):170-2. PubMed ID: 23773887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.